Gerber PA - Search Results

1

Mechanisms of skin aging induced by EGFR inhibitors.

Gerber PA, Buhren BA, Schrumpf H, Hevezi P, Bölke E, Sohn D, Jänicke RU, Belum VR, Robert C, Lacouture ME, Homey B. Gerber PA, et al. Support Care Cancer. 2016 Oct;24(10):4241-8. doi: 10.1007/s00520-016-3254-7. Epub 2016 May 10. Support Care Cancer. 2016. PMID: 27165055 Free PMC article.

2

Chemokine receptors in head and neck cancer: association with metastatic spread and regulation during chemotherapy.

Muller A, Sonkoly E, Eulert C, Gerber PA, Kubitza R, Schirlau K, Franken-Kunkel P, Poremba C, Snyderman C, Klotz LO, Ruzicka T, Bier H, Zlotnik A, Whiteside TL, Homey B, Hoffmann TK. Muller A, et al. Among authors: gerber pa. Int J Cancer. 2006 May 1;118(9):2147-57. doi: 10.1002/ijc.21514. Int J Cancer. 2006. PMID: 16331601 Free article.

3

[Febrile ulceronecrotic Mucha-Habermann syndrome].

Kukova G, Gerber PA, Neumann NJ, Bruch-Gerharz D, Homey B. Kukova G, et al. Among authors: gerber pa. Hautarzt. 2007 Oct;58(10):835-6. doi: 10.1007/s00105-007-1399-5. Hautarzt. 2007. PMID: 17846729 German. No abstract available.

4

Radiation-induced prevention of erlotinib-induced skin rash is transient: a new aspect toward the understanding of epidermal growth factor receptor inhibitor associated cutaneous adverse effects.

Gerber PA, Enderlein E, Homey B, Muller A, Boelke E, Budach W. Gerber PA, et al. J Clin Oncol. 2007 Oct 10;25(29):4697-8; author reply 4698-9. doi: 10.1200/JCO.2007.12.8330. J Clin Oncol. 2007. PMID: 17925571 No abstract available.

5

Tumor immune escape by the loss of homeostatic chemokine expression.

Pivarcsi A, Müller A, Hippe A, Rieker J, van Lierop A, Steinhoff M, Seeliger S, Kubitza R, Pippirs U, Meller S, Gerber PA, Liersch R, Buenemann E, Sonkoly E, Wiesner U, Hoffmann TK, Schneider L, Piekorz R, Enderlein E, Reifenberger J, Rohr UP, Haas R, Boukamp P, Haase I, Nürnberg B, Ruzicka T, Zlotnik A, Homey B. Pivarcsi A, et al. Among authors: gerber pa. Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19055-60. doi: 10.1073/pnas.0705673104. Epub 2007 Nov 19. Proc Natl Acad Sci U S A. 2007. PMID: 18025475 Free PMC article.

6

Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab.

Bölke E, Gerber PA, Lammering G, Peiper M, Müller-Homey A, Pape H, Giro C, Matuschek C, Bruch-Gerharz D, Hoffmann TK, Gripp S, Homey B, Budach W. Bölke E, et al. Among authors: gerber pa. Strahlenther Onkol. 2008 Feb;184(2):105-10. doi: 10.1007/s00066-008-1829-z. Strahlenther Onkol. 2008. PMID: 18259703

7

Images in clinical medicine. Erlotinib-induced hair alterations.

Gerber PA, Homey B. Gerber PA, et al. N Engl J Med. 2008 Mar 13;358(11):1175. doi: 10.1056/NEJMicm073144. N Engl J Med. 2008. PMID: 18337606 Free article. No abstract available.

8

Chloromas.

Bölke E, Gerber PA, Peiper M, Engers R, Pape H. Bölke E, et al. Among authors: gerber pa. Wien Klin Wochenschr. 2008;120(7-8):209. doi: 10.1007/s00508-008-0952-2. Wien Klin Wochenschr. 2008. PMID: 18500594 No abstract available.

9

The Koebner-phenomenon in epidermal growth factor receptor inhibitor-induced cutaneous adverse effects.

Gerber PA, Enderlein E, Homey B. Gerber PA, et al. J Clin Oncol. 2008 Jun 1;26(16):2790-2. doi: 10.1200/JCO.2007.16.0077. J Clin Oncol. 2008. PMID: 18509193 No abstract available.

10

Validity of S-100 B in patients after brain radiation.

Gripp S, Peiper M, Matuschek C, Giro C, Steinbach G, Hermsen D, van Griensven M, Budach W, Engers R, Gerber PA, Hefter H, Spiess B, Orth K, Bölke E. Gripp S, et al. Among authors: gerber pa. Eur J Med Res. 2008 Jun 24;13(6):299-303. Eur J Med Res. 2008. PMID: 18558557

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

210 results

Search Page